Skip To Main Content
Yingfei Xue on Muck Rack

Yingfei Xue

As seen in: Wiley Online Library, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingfei

Contact Yingfei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Increasing RB1 Expression by Targeting EZH2 in Triple‐Negative Breast Cancer

|
By Renfei Yang, Liyan Fei, Yingfei Xue, Yu Zhang
| Wiley Online Library Verified
1 Introduction Breast cancer remains a prominent global health concern, being the most commonly diagnosed cancer and the second leading cause of female mortality according to the latest 2024 cancer statistics report [1]. Subtyping of breast cancer, based on oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression levels, classifies it into Luminal-A, Luminal-B, HER2-positive and triple-negative breast cancer (TNBC) subtypes.
Open in Who Shared Issue with article?

Prevention by the CXCR2 antagonist SCH527123 of the calcification of porcine heart valve cusps implanted subcutaneously in rats

|
By CHU Amiens-Picardie, Hendrik Tevaearai Stahel, Ali Fatehi Hassanabad, Yingfei Xue
| Frontiers
1. Introduction Surgical or transcatheter aortic valve replacement (SAVR or TAVR) is currently the only effective curative treatment of aortic valve stenosis. The biological valves made from porcine or bovine tissue are the most commonly used valve substitutes today (1). Indeed, compared to mechanical valves, bioprostheses have a low risk of thrombosis and do not require lifelong anticoagulant treatment (2, 3). However, they are prone to failure.
Open in Who Shared Issue with article?

Performance of xenogeneic pulmonary visceral pleura as bioprosthetic heart valve cusps in swine

|
By Francesco Sturla, Anton Kutikhin, Martina Todesco, Yingfei Xue
| Frontiers
Introduction Transcatheter pulmonary valve replacement (TPVR) is becoming the treatment of choice in most congenital heart disease (CHD) patients with degeneration of prior right ventricular outflow tract repair.
Open in Who Shared Issue with article?
See all 3 articles